Daniel R. Chard - Mar 13, 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Mar 13, 2025
Transactions value $
-$109,272
Form type
4
Date filed
3/18/2025, 09:26 PM
Previous filing
Feb 11, 2025
Next filing
Mar 27, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability -$69.4K -5K -8.46% $13.87 54.1K Mar 13, 2025 Direct F1
transaction MED Common Stock Tax liability -$13.2K -944 -1.74% $13.94 53.2K Mar 16, 2025 Direct F1
transaction MED Common Stock Tax liability -$26.7K -1.86K -3.51% $14.35 51.3K Mar 17, 2025 Direct F1
holding MED Common Stock 149K Mar 13, 2025 The Dan and Allyson Family Irrevocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
F2 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.